Global Immunoassay Market Strategies & Trends Report 2023-2027: From Clinical to Consumer - Immunoassay's Expanding Footprint in Diagnostics

News provided by

Sep 11, 2023, 13:30 ET

DUBLIN, Sept. 11, 2023 /PRNewswire/ -- The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering.

In the ever-evolving landscape of the diagnostic industry, immunoassay is emerging as a steadfast workhorse, finding new relevance driven by the demands of the ongoing pandemic. The need for rapid, easily accessible diagnostics has propelled immunoassay to the forefront, as it adapts and advances in response to shifting market dynamics.

Advancements in genetic knowledge are opening up new avenues for immunoassay technologies, with multiplex capabilities becoming the standard. This transformation extends to rapid diagnostics, point-of-care solutions, biomarker exploration, and the expanding consumer market, while traditional immunoassay methods continue to hold a strong position within the growing realm of clinical diagnostics.

Within the realm of immunoassay instrumentation, multiple factors are fueling growth, including ongoing diagnostic breakthroughs, the retirement of older instruments driven by evolving technologies, wider consumer adoption, and the maturation of immunity-related technology.

However, these opportunities are not without their challenges. Heightened competition is exerting downward pressure on prices, while the threat from PCR-based instruments looms. Lower barriers to entry and potential drawbacks associated with wellness trends also present limitations to growth.

This dynamic landscape is characterized by enduring instruments, industry structures in flux due to declining instrument costs, and meticulous instrument specifications, which play a pivotal role in shaping the field. Innovations like CRISPR diagnostics further contribute to the evolving immunoassay landscape.

With profiles of over 60 companies, spanning both large and small players in this field, this comprehensive report offers invaluable insights into the pitfalls and opportunities that define the immunoassay industry. It equips stakeholders to make informed investment decisions and valuations, providing the latest data to navigate this ever-changing landscape with confidence.

Key Topics Covered:

Industry Overview

Players in a Dynamic Market

Academic Research Lab
Diagnostic Test Developer
Instrumentation Supplier
Chemical/Reagent Supplier
Pathology Supplier
Independent Clinical Laboratory
Public National/regional Laboratory
Hospital Laboratory
Physicians Office Lab (POLS)
Audit Body
Certification Body

The Clinical Laboratory Market Segments

Traditional Market Segmentation
Laboratory Focus and Segmentation
Hospital Testing Share
Economies of Scale
Hospital vs. Central Lab
Physician Office Lab's
Physician's and POCT

Immunoassay - Markets and Discussion

Instruments - Genetics changes the picture
RIA - A Technology Shows its Age
Immunoassay vs. PCR vs. Sequencing - A See Saw Battle
The Smart Shrinking Instrument - Serious Implications
Research Funding and Capital Expense - Instrument Pooling
Multiplex vs. POC - A Tradeoff Analysis
Reagents and Kits - Genetics changes the picture
Bigger Test Menus a Boon for Kit Market
Physician Office Labs - A New Frontier
Rapid and POCT to Threaten Instrument Markets
OTC and DTC - Huge Market Potential
Economies of Scale. Going Away?
Lower Barriers to Entry for Instruments/Analyzers
Miniturization and Technology Drive Acquisition

Immunoassay Recent Developments

Recent Developments - Importance and How to Use This Section
EDP Biotech, New Day Diagnostics to Merge
Sorrento Therapeutics Nabs Contract for Dx Platform
Beckman Coulter Diagnostics DxI 9000 Access Immunoassay Analyzer
Qorvo Eyes Multiplex Immunoassay
BioMerieux Launches New Products
Senzo to Commercialize Infectious Disease Lateral Flow Tests
Nanomix Plans Instrument, Test Launches
Startup GLX Analytix Prepares for Commercialization
Nonagen Gets CE Mark for Bladder Cancer Immunoassay
Qualigen Acquires Majority Stake in NanoSynex
Saladax Biomedical Using Immunoassay Dx
Prolight Diagnostics to Acquire Psyros Diagnostics
Quidel to Acquire Ortho Clinical Diagnostics
FDA Grants EUA to Xtrava Health
Alamar Biosciences Develops Immuno-Sandwich Platform
FDA grants breakthrough device to multiplex immunoassay
Quidel, Beckman Settle Cardiac Immunoassay Dispute
BGI Americas, Advaite Form SARS-CoV-2 Testing Partnership
BioMerieux Gets CE Mark for Three Dengue Immunoassays
COVID-19 Portfolio to Accelerate At-Home Infectious Disease Testing
Roche Diagnostics Expanding Testing Portfolio in 2021
PerkinElmer Long-Term Outlook
Quidel Updates Outlook for C19 Testing
Dx Companies Look at Multiplex Tests for SARS-CoV-2, Influenza
Becton Dickinson and NAT Diagnostics Acquisition

Market Trends

Factors Driving Growth

Diagnostic Factors
Changing Technologies Spur Early Instrument Retirement
Consumer Channels Open Wider
Immunity Technology Comes of Age

Factors Limiting Growth

Increased Competition Lowers Price
Threat from PCR Based Instruments
Lower Barriers to Entry
Wellness has a downside
Immunoassay Instrumentation
Instrumentation Tenacity
Declining Cost of Instruments Changes Industry Structure

LISTING of INSTRUMENT SPECIFICATIONS

Immunoassay - CRISPR Diagnostics

Market Guides

Immunoassay Market - Strategic Situation Analysis
Guide for Executives, Marketing, Sales and Business Development Staff
Guide for Management Consultants and Investment Advisors

Market Definition

Immunoassay Markets Definition In This Report

Enzyme Based
Immunofluorescence
Chemiluminescence
DNA/NAT
RIA & Other
Reagents/Kits, Analyzers, Software & Services
Infectious Disease
Auto Immune
Endocrinology
Oncology
Cardiology
Other Specialty

Market Definition

Methodology
Perspective: Healthcare and the IVD Industry
Global Healthcare Spending
Spending on Diagnostics
Important Role of Insurance for Diagnostics

Appendices

United States Medicare System: Laboratory Fees Schedule
The Most Used IVD Assays
The Highest Grossing Assays

Profiles of Key Companies

Abbott Laboratories
Abcam
Abionic
Accel Diagnostics
Applied BioCode
Arlington Scientific
Arrayit Corporation
Atomo Diagnostics
Aureum Diagnostics
Aurora Biomed
Autobio Diagnostics
AVIVA Systems Biology
Awareness Technology
Axis-Shield Diagnostics Ltd.
Beckman Coulter Diagnostics
Becton, Dickinson and Company
Biocartis
Biomatik
bioMerieux Diagnostics
Bioneer Corporation
Bio-Rad Laboratories, Inc.
BioTek Instruments
Boditech Med, Inc
Boster Biological Technology
Diamedix (Erba Diagnostics)
Diasorin S.p.A.
Dynex Technologies
Enzo Biochem
Eurofins Scientific
FUJIFILM Wako Diagnostics
Fujirebio
Gold Standard Diagnostics
Grifols
Hycor Biomedical
Immunodiagnostic Systems (IDS)
Immunodiagnostik AG
Inova Diagnostics
JR Biomedical
Luminex Corp
Maxim Biomedical
Mbio Diagnostics
Meso Scale Discovery
Millipore Sigma
Mindray
Molecular Devices
MP Biomedical
Operon
Ortho Clinical Diagnostics
Perkin Elmer
Qiagen
Quidel
R&D Systems
Randox Toxicology
Roche Molecular Diagnostics
SD Biosensor
Siemens Healthineers
Sysmex
Tecan
Thermo Fisher Scientific Inc.
TOSOH Bioscience
Veredus Laboratories
Vircell
YD Diagnostics
Zhejiang Orient Gene Biotech

Scope of the Report

Global Market by Application

Endocrinology Applications
Immune Applications
Oncology Applications
Infectious Disease Applications
Cardiology Applications
Other Applications

Immunoassay by Technology

Enzyme
Flourescence
Chemiluminescence
Nucleic Acid
Rapid/POC
Other Technology

Immunoassay by Product

Instrument
Reagents
Services

Immunoassay by User

Hospital
Outpatient Lab
POC/Other

12 Vision of the Future of Immunoassay

For more information about this report visit https://www.researchandmarkets.com/r/srmshg

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets